Novel therapies for epilepsy in the pipeline

Boulenouar Mesraoua (Corresponding author), Dirk Deleu, Dimitri M. Kullmann, Ashok K. Shetty, Paul Boon, Emilio Perucca, Mohamad A. Mikati, A. A. Asadi-Pooya

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

10 Citaten (Scopus)

Samenvatting

Despite the availability of many antiepileptic drugs (AEDs) (old and newly developed) and, as recently suggested, their optimization in the treatment of patients with uncontrolled seizures, more than 30% of patients with epilepsy continue to experience seizures and have drug-resistant epilepsy; the management of these patients represents a real challenge for epileptologists and researchers. Resective surgery with the best rates of seizure control is not an option for all of them; therefore, research and discovery of new methods of treating resistant epilepsy are of extreme importance. In this article, we will discuss some innovative approaches, such as P-glycoprotein (P-gp) inhibitors, gene therapy, stem cell therapy, traditional and novel antiepileptic devices, precision medicine, as well as therapeutic advances in epileptic encephalopathy in children; these treatment modalities open up new horizons for the treatment of patients with drug-resistant epilepsy.

Originele taal-2Engels
Pagina's (van-tot)282-290
Aantal pagina's9
TijdschriftEpilepsy and Behavior
Volume97
DOI's
StatusGepubliceerd - aug 2019

Vingerafdruk Duik in de onderzoeksthema's van 'Novel therapies for epilepsy in the pipeline'. Samen vormen ze een unieke vingerafdruk.

Citeer dit